2021
864-P: Treatment Burden and Quality of Life Conversations during Clinical Encounters: A Videographic Analysis
HAIDER S, EL KAWKGI O, CLARK J, BRESLIN M, BOEHMER K, MONTORI V, LIPSKA K. 864-P: Treatment Burden and Quality of Life Conversations during Clinical Encounters: A Videographic Analysis. Diabetes 2021, 70 DOI: 10.2337/db21-864-p.Peer-Reviewed Original ResearchTreatment burdenDiabetes mellitusSexual functionDiagnosis of DMClinical encountersSocial supportInternal medicine clinicPatient-clinician encountersClinician-patient encountersQuality of lifeCommon complicationDiabetes careMedicine clinicSexual dysfunctionPatient concernsPatient experienceSignificant burdenHypoglycemiaQoLProvider responsesPatientsVideographic analysisLife conversationsFamily medicineClinicians
2013
ASSOCIATION OF DIABETES MELLITUS WITH POST-MYOCARDIAL INFARCTION ANGINA: ANALYSIS OF THE TRIUMPH PROSPECTIVE COHORT STUDY
Arnold S, Spertus J, Lipska K, Tang F, Goyal A, McGuire D, Cresci S, Maddox T, Kosiborod M. ASSOCIATION OF DIABETES MELLITUS WITH POST-MYOCARDIAL INFARCTION ANGINA: ANALYSIS OF THE TRIUMPH PROSPECTIVE COHORT STUDY. Journal Of The American College Of Cardiology 2013, 61: e1561. DOI: 10.1016/s0735-1097(13)61561-2.Peer-Reviewed Original Research
2008
Cardiovascular risk-benefit ratio of thiazolidinediones
Lipska K, Inzucchi S. Cardiovascular risk-benefit ratio of thiazolidinediones. Current Cardiovascular Risk Reports 2008, 3: 42-50. DOI: 10.1007/s12170-009-0008-9.Peer-Reviewed Original ResearchRisk-benefit ratioType 2 diabetes mellitusActual cardiovascular outcomesSurrogates of atherosclerosisDifferential clinical effectsInsulin-sensitizing thiazolidinedionesEffective antihyperglycemic agentCardiovascular eventsCardiovascular outcomesCardiovascular implicationsBlood pressureDiabetes mellitusEndothelial functionHeart failureClinical effectsInsulin resistanceAntihyperglycemic agentsFluid retentionLipid profileThiazolidinedionesPatientsAvailable membersBeneficial impactMellitusT2DM